Search Results - "E. Ben-Baruch"

Risk factors for severity and relapse of pseudomembranous colitis in an elderly population by Moshkowitz, Menachem, Ben-Baruch, Efrat, Kline, Zeev, Shimoni, Zvi, Niven, Mark, Konikoff, Fred

“…Objective  Pseudomembranous colitis (PMC) is well recognized as an important cause of diarrhoea in patients receiving antibiotics, with significant…”
Get full text

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer by Mirza, Mansoor R, Monk, Bradley J, Herrstedt, Jørn, Oza, Amit M, Mahner, Sven, Redondo, Andrés, Fabbro, Michel, Ledermann, Jonathan A, Lorusso, Domenica, Vergote, Ignace, Ben-Baruch, Noa E, Marth, Christian, Mądry, Radosław, Christensen, René D, Berek, Jonathan S, Dørum, Anne, Tinker, Anna V, du Bois, Andreas, González-Martín, Antonio, Follana, Philippe, Benigno, Benedict, Rosenberg, Per, Gilbert, Lucy, Rimel, Bobbie J, Buscema, Joseph, Balser, John P, Agarwal, Shefali, Matulonis, Ursula A

“…Among patients with platinum-sensitive, recurrent ovarian cancer, the use of niraparib, a PARP inhibitor, was associated with a significantly longer duration…”
Get full text

Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer by Denys, Hannelore, Martinez-Mena, Corina L., Martens, Marc T., D’Hondt, Randal G., Graas, Marie-Pascale L., Evron, Ella, Fried, Georgeta, Ben-Baruch, Noa E., Vulsteke, Christof, Van Steenberghe, Mona M.

“…Purpose The subcutaneous (SC) administration of trastuzumab is highly preferred by patients. At home, administration of trastuzumab SC might further improve…”
Get full text

Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial by Delaloge, S., Cella, D., Ye, Y., Buyse, M., Chan, A., Barrios, C.H., Holmes, F.A., Mansi, J., Iwata, H., Ejlertsen, B., Moy, B., Chia, S.K.L., Gnant, M., Smichkoska, S., Ciceniene, A., Martinez, N., Filipović, S., Ben-Baruch, N.E., Joy, A.A., Langkjer, S.T., Senecal, F., de Boer, R.H., Moran, S., Yao, B., Bryce, R., Auerbach, A., Fallowfield, L., Martin, M.

“…We report longitudinal health-related quality-of-life (HRQoL) data from the international, randomized, double-blind, placebo-controlled phase III ExteNET…”
Get full text

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer by Mirza, Mansoor R, Monk, Bradley J, Herrstedt, Jørn, Oza, Amit M, Mahner, Sven, Redondo, Andrés, Fabbro, Michel, Ledermann, Jonathan A, Lorusso, Domenica, Vergote, Ignace, Ben-Baruch, Noa E, Marth, Christian, Mądry, Radoslaw, Christensen, René D, Berek, Jonathan S, Dørum, Anne, Tinker, Anna V, du Bois, Andreas, González-Martín, Antonio, Follana, Philippe, Benigno, Benedict, Rosenberg, Per, Gilbert, Lucy, Rimel, Bobbie J, Buscema, Joseph, Balser, John P, Agarwal, Shefali, Matulonis, Ursula A

“…(Abstracted from N Engl J Med 2016;375(22):2154–2164)The initial response rate to platinum and taxane treatment in patients with advanced ovarian cancer is…”
Get full text

Worker's perceptions of time, time-use-attitudes and productivity by E. Ben-Baruch, C. P. H. Myburgh, E. C. Anderssen

“…Decreasing productivity and increasing wage demands are singled out as being crucial problems facing the economy of South Africa. Changes in the time…”
Get full text

Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial by Delaloge, S, Cella, D, Ye, Y, Buyse, M, Chan, A, Barrios, C H, Holmes, F A, Mansi, J, Iwata, H, Ejlertsen, B, Moy, B, Chia, S K L, Gnant, M, Smichkoska, S, Ciceniene, A, Martinez, N, Filipović, S, Ben-Baruch, N E, Joy, A A, Langkjer, S T, Senecal, F, de Boer, R H, Moran, S, Yao, B, Bryce, R, Auerbach, A, Fallowfield, L, Martin, M

“…We report longitudinal health-related quality-of-life (HRQoL) data from the international, randomized, double-blind, placebo-controlled phase III ExteNET…”
Get full text

Abstract P4-21-17: BELIS: Safety and tolerability of at home administration of trastuzumab (Herceptin®) subcutaneous for the treatment of patients with HER2-positive early breast cancer by Cocquyt, VF, Martinez-Mena, CL, Martens, MT, D'Hondt, RG, Graas, M-PL, Evron, E, Fried, G, Ben-Baruch, NE, Dijkstra, AC, Van De Walle, EI

“…Abstract Background: Trastuzumab (Herceptin®; H) is a standard component of adjuvant treatment in patients with HER2+ early breast cancer (eBC) and is…”
Get full text

Clinical manifestations and outcome of pseudomembranous colitis in an elderly population in Israel by Moshkowitz, Menachem, Baruch, Efrat Ben, Kline, Zeev, Gelber, Moshe, Shimoni, Zvi, Konikoff, Fred

“…Pseudomembranous colitis is a well-recognized cause of diarrhea in patients receiving antibiotics and has significant consequences in terms of morbidity,…”
Get full text

Abstract P1-02-07: Discordance for low and intermediate levels (1+ or 2+ by IHC) of HER2 protein expression in the phase III PRESENT trial by Rugo, HS, Melisko, M, Ben-Baruch, NE, Price Hiller, J, Dahkil, S, Sutton, L, Mazanet, R, Mittendorf, E

“…Abstract Background Significant discordance has been described between different laboratories and between testing methodologies for HER2 overexpression and…”
Get full text

Educational Administration and Policy Making: The Case of Israel by Gamson, Zelda F.

Get full text